Is penicillin G (Penicillin G) acceptable for the treatment of syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Penicillin G Acceptable for Syphilis Treatment?

Yes, penicillin G is not only acceptable but remains the drug of choice for treating all stages of syphilis, with specific formulations and dosing regimens determined by the stage of infection. 1, 2

Why Penicillin G is the Gold Standard

Parenteral penicillin G is the preferred drug for treatment of all stages of syphilis, supported by more than 40 years of clinical experience. 1, 2 The FDA has approved penicillin G for treatment of syphilis, including congenital and neurosyphilis. 3

Key Formulations Used

Different formulations of penicillin G are used depending on the stage and location of infection:

  • Benzathine penicillin G is the standard formulation for early and late latent syphilis, administered intramuscularly 2, 4
  • Aqueous crystalline penicillin G is required for neurosyphilis due to superior CNS penetration, administered intravenously 1, 2
  • Procaine penicillin G (with probenecid) can be used as an alternative for neurosyphilis only when combined with probenecid, as procaine penicillin alone does not achieve adequate CSF levels 2

Stage-Specific Treatment Regimens

Primary and Secondary Syphilis

  • Benzathine penicillin G 2.4 million units IM as a single dose is the recommended treatment 2, 5, 4
  • A recent 2025 randomized controlled trial demonstrated that one dose of 2.4 million units was noninferior to three weekly doses, with 76% achieving serologic response at 6 months in both HIV-infected and non-HIV-infected patients 6

Early Latent Syphilis

  • Benzathine penicillin G 2.4 million units IM as a single dose 2
  • Early latent is defined as infection acquired within the preceding year based on documented seroconversion, fourfold titer increase, recent symptoms, or exposure to a partner with documented early syphilis 2

Late Latent and Tertiary Syphilis

  • Benzathine penicillin G 7.2 million units total, administered as three doses of 2.4 million units IM at weekly intervals 2, 7, 4
  • Critical pitfall: Always perform CSF examination before treating tertiary syphilis to exclude neurosyphilis, which requires entirely different treatment 7, 5

Neurosyphilis

  • Aqueous crystalline penicillin G 18-24 million units per day IV (administered as 3-4 million units every 4 hours or continuous infusion) for 10-14 days 1, 2
  • Alternative: Procaine penicillin 2.4 million units IM daily PLUS probenecid 500 mg orally four times daily for 10-14 days (only if compliance can be ensured) 1, 2

Special Populations

HIV-Infected Patients

  • Use the same treatment regimens as HIV-negative patients for all stages of syphilis 2, 5
  • Available data suggest no clinical benefit to more than one dose of benzathine penicillin G for early syphilis in HIV-infected patients 1, 2
  • However, closer follow-up is mandatory to detect potential treatment failure or disease progression 2, 7

Pregnant Women

  • Penicillin is the ONLY therapy proven to prevent maternal transmission and treat fetal infection 2, 7, 5
  • Pregnant women with penicillin allergy MUST undergo desensitization followed by penicillin treatment—no alternatives are acceptable 2, 7, 5
  • All pregnant women should be screened for syphilis at first prenatal visit, during third trimester, and at delivery 2

When Penicillin Cannot Be Used

Non-Pregnant, Penicillin-Allergic Adults

  • For primary, secondary, or early latent syphilis: Doxycycline 100 mg orally twice daily for 14 days 1, 2, 5
  • For late latent syphilis: Doxycycline 100 mg orally twice daily for 28 days 1, 2
  • A 2022 retrospective study showed doxycycline had slightly lower success rates than penicillin, particularly in late and undetermined syphilis infections, though differences were not statistically significant 8

Alternative Considerations

  • Ceftriaxone 1 gram IV/IM daily for 10 days is a reasonable alternative based on randomized trial data showing comparable efficacy to benzathine penicillin 2, 5
  • Azithromycin should NOT be used in the United States due to widespread macrolide resistance and documented treatment failures 2, 5

Critical Pitfalls to Avoid

  • Never use oral penicillin preparations—they are completely ineffective for syphilis treatment 2, 5
  • Never skip CSF examination before treating tertiary syphilis—missing neurosyphilis leads to treatment failure as the benzathine penicillin regimen is inadequate for CNS involvement 7, 5
  • Never switch between different nontreponemal test methods (RPR vs VDRL) when monitoring response—results cannot be directly compared 2, 5
  • Never substitute non-penicillin antibiotics in pregnancy—only penicillin prevents congenital syphilis 2, 7

Follow-Up Monitoring

  • Repeat quantitative nontreponemal tests (RPR or VDRL) at 6,12, and 24 months after treatment 2, 7
  • Expect a fourfold decline in titer within 6 months for primary/secondary syphilis 2, 5
  • Expect a fourfold decline in titer within 12-24 months for late syphilis 2, 7
  • Treatment failure is defined as persistent symptoms, sustained fourfold increase in titers, or failure of initially high titers to decline appropriately 2, 7

Jarisch-Herxheimer Reaction

  • An acute febrile reaction may occur within 24 hours after any syphilis therapy, especially in early syphilis, and includes headache, myalgia, and fever 2, 7
  • In pregnant women during the second half of pregnancy, this reaction may precipitate premature labor or fetal distress 2
  • Patients should be counseled about this possibility and advised to seek immediate medical attention if concerning symptoms develop 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Syphilis: A Review.

JAMA, 2025

Guideline

Syphilis Diagnosis and Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Stage 3 (Tertiary) Syphilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.